Introducing Our Life Sciences Webinar Series
We will be kicking off our complimentary Life Sciences CLE Program starting in January of 2025. Thought-leaders will delve into key issues shaping intellectual property in biotechnology, pharmaceuticals, and medical devices. These sessions will provide critical insights into patent strategies, regulatory developments, and litigation trends impacting the life sciences sector. Designed for legal professionals and industry leaders, this program ensures you’re prepared to navigate the rapidly evolving IP landscape.
If you have any suggestions for topics you’re eager to explore, please let us know using the form below.
Sign up below to be notified of our upcoming CLEs
Program Faculty
Andrew Wasson, Partner
Andrew Wasson is a partner and Chair of Haug Partners’ FDA practice in the New York office. Andrew has a broad range of experience in both the brand and generic side of pharmaceuticals, especially with respect to issues involving intellectual property law and regulatory law.
Wan Chieh (Jenny) Lee, Partner
Ms. Lee combines extensive experience across all aspects of patent law with a strong ability to analyze complex technical information to provide clients with business-oriented patent strategies and insights.
Andrew Roper, Partner
Andrew Roper is a partner in Haug Partners’ New York offices. The majority of his practice focuses on patent litigation. Additionally, he performs due diligences, and evaluations of IP assets.
Kaitlin Farrell, Partner
Mrs. Farrell relies on her technical background, trial experience, and competitive drive to develop results-oriented strategies and achieve favorable outcomes for clients.
